These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 24457988)
1. Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer. Han X; Yan S; Weijie Z; Feng W; Liuxing W; Mengquan L; Qingxia F Cancer Gene Ther; 2014 Feb; 21(2):60-7. PubMed ID: 24457988 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition. Ma C; Wei F; Xia H; Liu H; Dong X; Zhang Y; Luo Q; Liu Y; Li Y Int J Oncol; 2017 May; 50(5):1739-1748. PubMed ID: 28393237 [TBL] [Abstract][Full Text] [Related]
3. MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2. Ma M; He M; Jiang Q; Yan Y; Guan S; Zhang J; Yu Z; Chen Q; Sun M; Yao W; Zhao H; Jin F; Wei M Int J Biol Sci; 2016; 12(4):397-408. PubMed ID: 27019625 [TBL] [Abstract][Full Text] [Related]
4. miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells. Ye Z; Zhao L; Li J; Chen W; Li X Int J Gynecol Cancer; 2015 Nov; 25(9):1574-81. PubMed ID: 26501435 [TBL] [Abstract][Full Text] [Related]
5. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537 [TBL] [Abstract][Full Text] [Related]
6. KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. Zhang H; Liu L; Wang Y; Zhao G; Xie R; Liu C; Xiao X; Wu K; Nie Y; Zhang H; Fan D J Cancer Res Clin Oncol; 2013 Jun; 139(6):1033-42. PubMed ID: 23504025 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
8. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Wang H; Wu Q; Zhang Y; Zhang HN; Wang YB; Wang W Cell Mol Biol Lett; 2017; 22():22. PubMed ID: 29118814 [TBL] [Abstract][Full Text] [Related]
9. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1. Chen XB; Li W; Chu AX J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272 [TBL] [Abstract][Full Text] [Related]
11. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
12. Hu X; Li D; Zhan J; Yang C; Wang P; Meng X; Xu S; Che X; Xu L DNA Cell Biol; 2024 May; 43(5):245-257. PubMed ID: 38489601 [TBL] [Abstract][Full Text] [Related]
13. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772 [TBL] [Abstract][Full Text] [Related]
14. TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells. Ye Z; Li J; Han X; Hou H; Chen H; Zheng X; Lu J; Wang L; Chen W; Li X; Zhao L J Exp Clin Cancer Res; 2016 May; 35():72. PubMed ID: 27141829 [TBL] [Abstract][Full Text] [Related]
15. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study. Nalla LV; Gondaliya P; Kalia K; Khairnar A Mol Biol Rep; 2022 Jul; 49(7):6987-6996. PubMed ID: 35486287 [TBL] [Abstract][Full Text] [Related]
16. Shin JM; Park JH; Yang HW; Moon JW; Lee HM; Park IH Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768968 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression. Jiang L; Xie X; Bi R; Ding F; Mei J Biomed Pharmacother; 2020 May; 125():109049. PubMed ID: 32092827 [TBL] [Abstract][Full Text] [Related]
18. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway. Wang J; Liang S; Duan X J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231 [TBL] [Abstract][Full Text] [Related]
20. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]